NASDAQ:ELYM
Eliem Therapeutics, Inc.
- Stock
Last Close
8.18
17/05 20:00
Market Cap
79.27M
Beta: -
Volume Today
318.37K
Avg: 17.85K
PE Ratio
−1.98
PFCF: −2.60
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -6.55M - | -20.67M 215.69% | -47.48M 129.73% | -45.24M 4.71% | ||
depreciation and amortization | 1.84M - | |||||
deferred income tax | -1.84M - | -1.39M 24.66% | ||||
stock based compensation | 707K - | 3.74M 428.57% | 6.99M 87.08% | |||
change in working capital | -309K - | -2.94M 850.16% | -4.17M 42.10% | 210K 105.03% | ||
accounts receivables | ||||||
inventory | ||||||
accounts payables | 17K - | -24K 241.18% | 150K 725% | -653K 535.33% | ||
other working capital | -326K - | -2.91M 793.25% | -4.32M 48.42% | 863K 119.97% | ||
other non cash items | 1.85M - | 8.80M 376.14% | 11.84M 34.59% | 2.06M 82.57% | ||
net cash provided by operating activities | -5.01M - | -14.10M 181.51% | -36.07M 155.87% | -37.37M 3.60% | -20.60M 44.88% | |
investments in property plant and equipment | ||||||
acquisitions net | ||||||
purchases of investments | -114.97M - | -87.96M 23.49% | ||||
sales maturities of investments | 122.40M - | |||||
other investing activites | 8.08M - | 68.98M - | ||||
net cash used for investing activites | 8.08M - | -114.97M 1,523.25% | 34.44M 129.96% | 68.98M 100.29% | ||
debt repayment | ||||||
common stock issued | 26.24M - | 4.92M 81.23% | 83.14M 1,588.20% | |||
common stock repurchased | ||||||
dividends paid | ||||||
other financing activites | 26.24K - | 4.92K 81.23% | 94.09M 1,910,316.24% | 841K - | ||
net cash used provided by financing activities | 26.24M - | 4.92M 81.23% | 177.23M 3,498.62% | 841K - | ||
effect of forex changes on cash | -12K - | 359K 3,091.67% | 245K 31.75% | -408K 266.53% | ||
net change in cash | 21.22M - | -736K 103.47% | 26.43M 3,691.71% | -3.34M 112.62% | 49.22M 1,575.07% | |
cash at beginning of period | 21.22M - | 20.49M 3.47% | 46.92M 129.03% | |||
cash at end of period | 21.22M - | 20.49M 3.47% | 46.92M 129.03% | 43.59M 7.11% | 49.22M 12.94% | |
operating cash flow | -5.01M - | -14.10M 181.51% | -36.07M 155.87% | -37.37M 3.60% | -20.60M 44.88% | |
capital expenditure | ||||||
free cash flow | -5.01M - | -14.10M 181.51% | -36.07M 155.87% | -37.37M 3.60% | -20.60M 44.88% |
All numbers in USD (except ratios and percentages)